PDL BioPharma, Inc. Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)
PDL BioPharma, Inc. had Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) of $20.27 million as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:LiabilitiesFairValueDisclosureRecurring · last filed 2018-11-07
- 2018-09-30: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $20.27M.
- 2018-06-30: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $20.04M.
- 2018-03-31: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $41.40M.
- 2017-12-31: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $42.00M.
| Period end | Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) |
|---|---|
| 2018-09-30 | $20.27M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $20.04M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $41.40M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $42.00M 10-Q · filed 2018-11-07 |
| 2017-09-30 | $45.00M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $133.30M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $132.09M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $130.65M 10-Q · filed 2017-11-13 |
| 2016-09-30 | $136.45M 10-Q · filed 2016-11-03 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-03 |